CDSCO License for Bedrail pad
Medical Device Information
Important Notice for Class A Devices
Class A Non-sterile Non Measuring devices are exempt from MD5 and MD15 licenses. Only CDSCO registration is required as per GSR 777(E).
Intended Use
A device which is formed as a flat or contoured fitted cushion made of soft, non-irritating materials designed to protect the patient from coming into contact with the bedrails and inadvertently hurting or injuring themselves. It will be mainly used for patients that have little self- control, infants and very young children. This is a reusable device.

Comprehensive Guide to CDSCO Licensing for Class A Bedrail Pad
At our consultancy, with over 25 years of experience and having supported 500+ companies in navigating the CDSCO licensing landscape, we understand the critical importance of regulatory compliance for medical devices like the Bedrail Pad. This device, classified as Class A under CDSCO regulations, plays a vital role in pediatrics and neonatology by protecting vulnerable patients—such as infants and young children—from injury caused by contact with bedrails.
Ensuring your Bedrail Pad is legally marketable in India requires a clear grasp of the CDSCO regulatory framework, license application processes, and practical compliance strategies. This comprehensive guide is tailored specifically for manufacturers and importers aiming to enter the Indian market with this Class A reusable device.
CDSCO Regulatory Framework for Class A Bedrail Pads
The Central Drugs Standard Control Organization (CDSCO) regulates medical devices under the Drugs and Cosmetics Act, 1940, and associated rules. Class A devices, being low risk, are subject to licensing at the State level through the MD5 license pathway.
The Bedrail Pad, intended to cushion and protect pediatric patients, falls under Class A based on its intended use and low risk profile as outlined in the CDSCO Medical Device Classification.
Understanding this classification is key, as it dictates the regulatory route, documentation, and fees.
Risk Classification and License Requirements for Bedrail Pads
- Device Class: Class A (Low Risk)
- License Type: MD5 Manufacturing License
- Authority: State Licensing Authority
- Application Form: MD3
Class A devices require manufacturers to obtain an MD5 license after a mandatory test license phase (MD13) and product testing from government-approved laboratories.
Manufacturing License Process for Bedrail Pad (MD5 License)
Step 1: Obtain Test License (MD13)
Before applying for the MD5 manufacturing license, you must obtain a test license on Form MD13. This license allows you to manufacture limited quantities for testing purposes.
- Timeline: Approximately 1.5 to 2 months
- Purpose: To facilitate product testing and validation
Step 2: Product Testing
The Bedrail Pad must be tested at CDSCO-recognized testing laboratories to confirm compliance with applicable standards for safety and performance. Refer to the list of Testing Laboratories approved by CDSCO.
- Testing Duration: 3-4 weeks typically
Step 3: Document Preparation
Compile all required documentation, including technical files and quality management system (QMS) evidence.
Step 4: Application for MD5 License (Form MD3)
Submit your application via the CDSCO MD Online Portal. The application includes uploading documents and paying fees.
Step 5: Audit by Notified Body
An audit of your manufacturing site and QMS will be conducted by a notified body. You can check the list of notified bodies authorized for Class A device audits.
Step 6: Query Resolution
Address any queries raised by the licensing authority or notified body promptly to avoid delays.
Step 7: Grant of MD5 License
Upon successful audit and document approval, the State Licensing Authority grants the MD5 license (Form MD5), authorizing manufacturing for commercial sale.
Manufacturing License Documents Required for Bedrail Pad
To ensure a smooth application process, prepare the following documents meticulously:
- Company Constitution Documents (Incorporation certificate, MOA, and AOA)
- Proof of Ownership or Lease of Manufacturing Premises
- Technical Staff Qualification and Experience Certificates
- Fire NOC and Pollution Control Board NOC
- Device Master File (DMF) detailing design, materials, and specifications. Our Device Master File Guide provides a thorough overview.
- Plant Master File describing manufacturing infrastructure. Refer to our Plant Master File Guide
- Essential Principles Checklist demonstrating compliance with safety and performance requirements
- Risk Management File outlining hazard analysis and mitigation strategies. See our Risk Management Guide
- Product Test Reports from CDSCO-approved labs
- Labels and Instructions for Use (IFU) tailored for pediatric use
- Quality Management System (QMS) documents, preferably ISO 13485 certified
Attention to detail in document preparation significantly reduces review time.
Import License Process for Bedrail Pad (MD15 License)
While our focus here is on manufacturing, importers of Bedrail Pads require the MD15 Import License granted by the Central Licensing Authority.
This process involves:
- Document preparation including Manufacturing License from the country of origin, Free Sale Certificate, ISO 13485:2016, CE Certificate, Device and Plant Master Files, and Wholesale License
- Application submission on the CDSCO MD Online Portal
- Query resolution
- License grant typically within 5-6 months
For detailed import licensing guidance, our Import License Guide can be a valuable resource.
Timeline and Processing Duration
Process Step | Approximate Duration |
---|---|
Test License (MD13) | 1.5 – 2 months |
Product Testing | 3 – 4 weeks |
Document Preparation | 2 – 3 weeks (varies) |
MD5 License Application | 3 – 4 months total (includes audit and query resolution) |
Overall, expect around 3 to 4 months from test license initiation to MD5 license grant.
Government Fees and Costs
- Test License (MD13): Nominal fees as per CDSCO norms
- MD5 License Application: Rs. 5,000 per application
- Product Fee: Rs. 500 per product (Bedrail Pad counts as one product)
- Audit and Testing Costs: Vary depending on notified body and testing lab charges
Budgeting accurately for these costs upfront prevents surprises.
Common Challenges and Solutions
Challenge: Delays in product testing due to lab backlogs
Solution: Engage with approved testing labs early, book slots in advance, and prepare samples meticulously.
Challenge: Incomplete or inconsistent documentation
Solution: Use document checklists and consult experienced regulatory experts during preparation.
Challenge: Audit non-compliance
Solution: Conduct internal mock audits using notified body checklists to ensure readiness.
Challenge: Query resolution delays
Solution: Assign a dedicated regulatory officer to respond quickly and comprehensively.
Expert Consultation and Support
With over two decades of regulatory consultancy experience, we offer end-to-end support—from test license application, documentation, audit preparation, to final license grant. Our deep understanding of CDSCO protocols and proactive approach helps clients avoid common pitfalls and accelerates time to market.
Getting Started with Your CDSCO License Application for Bedrail Pad
- Assess Device Classification: Confirm Class A status using official CDSCO guidelines.
- Initiate Test License Application: Prepare and submit Form MD13 via the CDSCO MD Online Portal.
- Coordinate Product Testing: Engage with CDSCO-approved labs early to schedule testing.
- Compile Complete Documentation: Utilize our guides on Device Master File and Plant Master File to prepare robust submissions.
- Plan for Audit: Liaise with notified bodies and conduct pre-audit assessments.
- Submit MD5 License Application: Upload all documents and fees on the CDSCO portal.
- Monitor and Resolve Queries: Respond promptly to communications from CDSCO and auditors.
By following these actionable steps and leveraging expert guidance, manufacturers of Bedrail Pads can confidently navigate the regulatory process and achieve timely CDSCO license approval, enabling safe and compliant access to the Indian healthcare market.
For personalized assistance and detailed project planning, contact our regulatory consultancy team today.